AMGN

Amgen Inc. (AMGN)

Last Price$283.6(4.2%)
Market Cap$175.7B
LTM Revenue
$32.4B
YoY Growth
+20.9%
3Y CAGR
+8.0%
5Y CAGR
+6.7%
Stock quality & Intrinsic value
5/10
35.2% overvalued

Amgen Inc. Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$10.6B
$12.4B
$14.3B
$14.8B
$15.0B
$14.6B
$15.1B
$15.6B
$17.3B
$18.7B
$20.1B
$21.7B
$23.0B
$22.8B
$23.7B
$23.4B
$25.4B
$26.0B
$26.3B
$28.2B
See the AMGN
full fundamental analysis
View -->
Overvalued or undervalued?
Check the intrinsic value for AMGN
Explore -->

Amgen Inc. (AMGN) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Amgen Inc.'s Revenue?

As of today, Amgen Inc.'s last 12-month Revenue is $32.4B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Amgen Inc.'s Revenue growth rate?

Over the last year, Amgen Inc.'s Revenue growth was 20.9%. The average annual Revenue growth rates for Amgen Inc. have been 8.8% over the past three years, 6.7% over the past five years.

3) Is Amgen Inc.'s Revenue growth rate Good?

Over the last year, Amgen Inc.'s Revenue growth was 20.9%, which is higher than industry growth of 0.1%. It indicates that Amgen Inc.'s Revenue growth is Good.

4) How does Amgen Inc.'s Revenue growth rate compare to its peers?

Over the last year, Amgen Inc.'s Revenue growth was 20.9%, which is higher than peer median growth of 5.6%. The list of peers includes JNJ, SNY, MRK, PFE, ABBV, AZN, NVS, BMY, LLY, GILD etc.